Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2026 Aug 8;16:37160. doi: 10.1038/s41598-026-65480-x

Host CD59 potentiates the type III secretion system in Yersinia pseudotuberculosis

Kristen J Davis 1,2, Kerri-Lynn Sheahan 1,3,5, Connor S Murphy 1,3,6, Joshua J Whiteley 4, Bree B Aldridge 1,3,4, Ralph R Isberg 1,3,✉
PMCID: PMC13739739

Abstract

Type III secretion systems (T3SS) play critical roles in disease for many Gram-negative pathogens. Although the structural details of T3SS assembly have been extensively studied, the intimate interactions between T3SS components and the target host plasma membrane are poorly characterized. A previous RNA interference (RNAi) study identified the GPI-linked surface protein CD59 as a critical host component that supports the translocation of Yersinia pseudotuberculosis (Yptb) T3SS effectors into the host cytosol. We show here that both depletion and increased levels of CD59 reduced Yptb T3SS pore formation and Yop translocation into host target cells. CD59 is unlikely to act as a receptor for the T3SS translocon, as physical blockade of CD59 or enzymatic removal of all GPI-linked surface proteins had no effect on T3SS function. Consistent with its importance in supporting T3SS function, efficient bacterial effector-mediated focal adhesion disassembly was dependent on CD59. Surprisingly, depletion of CD59 interfered with the rearrangement of the lipid raft marker GM1 that occurs after Yptb adhesion to host cells, indicating that CD59 supports lipid microdomain dynamics. Consistent with a role in modulating lipid composition, the loss of CD59 led to the accumulation of phosphatidylcholine and alterations in both fatty acid chain lengths and saturation levels. This work points to a role for CD59 in maintaining plasma membrane dynamics necessary for efficient T3SS translocon function. In addition, a polarization index is described that quantifies the asymmetric association of membrane compartments with organelles.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1038/s41598-026-65480-x.

Keywords: Yersinia, CD59, Focal adhesions, Type III secretion, Lipids

Subject terms: Biochemistry, Cell biology, Immunology, Microbiology

Introduction

The pathogenesis of Yersinia pseudotuberculosis (Yptb) requires the Type III Secretion System (T3SS), which delivers bacterial effectors into host cells, thereby misregulating host signaling pathways and facilitating evasion of innate immune responses1–3. The T3SS is encoded on a ~ 70-kb virulence plasmid present in the three human-pathogenic Yersinia species: the enteropathogenic Y. enterocolitica and Y. pseudotuberculosis, and the causative agent of bubonic plague, Y. pestis4–6. The secretion apparatus is structurally and functionally well conserved among many Gram-negative pathogens, with the Yersinia syringe-like nanomachine delivering bacterial effector proteins, called Yops (Yersinia outer proteins), into the host cell cytosol2,7. There is a core set of six Yops, with YopT absent in most Yptb strains (including YPIII, the strain used in this study)8,9. Although much work has been done to describe the structure and function of the T3SS, how the host cell supports its function remains largely unknown.

Yops prevent engulfment by professional phagocytes and interfere with reactive oxygen-mediated killing, allowing successful extracellular bacterial replication and survival in host tissues, even with neutrophil-adherent bacteria3,10. YopE, for example, is a GTPase activating protein (GAP) that inactivates Rho-family GTPases such as RhoA, Cdc42, and Rac that regulate actin cytoskeletal function required for phagocytosis and production of reactive oxygen species via assembly of the NADPH oxidase complex11,12. Interestingly, it has been shown that host cell Rho GTPase activity is initially required for efficient translocation of Yops13, underscoring that modulation of the actin cytoskeleton plays multiple roles in establishing disease. Several other host factors have been identified that are important for T3SS function, including host cell sulfation and fucosylation in Vibrio parahaemolyticus, and DNAJC5 in Pseudomonas aeruginosa, which acts as a chaperone for effector translocation14–16.

We previously identified mammalian proteins important for YopE function using a mammalian siRNA knockdown library and a FRET-based Rho GTPase biosensor17. The screen identified host proteins, including the chemokine receptor CCR5, which has been shown to affect T3SS function, as well as other proteins involved in cell adhesion, signaling, and membrane trafficking17. These included CD59, a glycosyl-phosphatidylinositol (GPI)-anchored protein on the surface of most mammalian cell types that functions as a self-recognition marker to protect against complement attack18. The presence of CD59 on mammalian cells prevents the oligomerization of complement proteins into membrane attack complexes (MACs) upon activation, whereas microorganisms lacking this defense are targeted for destruction19–21. CD59 is also a direct receptor for some bacterial cholesterol-dependent pore-forming cytolysins and may play a role in forming the T3SS translocation channel22,23. In addition, CD59 is an important component of microdomains in the plasma membrane, known as lipid rafts, which are important for critical cell functions such as membrane trafficking, chemokine signaling, and immune cell activation24. Studies in several similar pathogens, including Shigella, EPEC, and Salmonella, have revealed that functional lipid rafts on the host cell surface play an important role in supporting microbial adhesion, T3SS translocon pore insertion, and delivery of translocated effector substrates25–27.

In this study, we show that cells lacking CD59 are associated with aberrant mobilization of host cell plasma membrane components in response to Yptb-target cell contact, resulting in defective translocon pore formation and effector translocation.

Results

Alterations in surface expression of host cell CD59 result in inefficient pore formation by Yptb

The plasma membrane protein CD59 was identified as a candidate for supporting Yop translocation, based on a pooled shRNA knockdown approach to detect mammalian proteins important for Yptb YopE function17. Verification of the hit revealed that when host cell CD59 was knocked down by shRNA, significant T3SS defects were evident, as assessed by secondary assays for YopB/D-dependent pore formation and YopH translocation17. These data were consistent with a general defect in T3SS translocator function rather than direct modulation of YopE activity. To pursue these results further, a cloned CD59 knockout HEK 293T line (CD59 KO) was constructed28. Cell surface labeling of the CD59 KO cell line with anti-CD59-FITC, followed by flow cytometry analysis, resulted in fluorescence indistinguishable from that of an isotype control (Fig. 1A). In contrast, WT HEK 293T cells, showed robust labeling with the anti-CD59-FITC conjugate (Fig. 1A).

Fig. 1.

Fig. 1

Knockout and increased surface levels of host cell CD59 result in inefficient pore formation when challenged by Yptb. (A) WT and CD59 KO HEK 293T cells were probed with either FITC-conjugated α-human CD59 or isotype control and analyzed by flow cytometry to quantitate cell surface CD59. Histogram displays total counts for fluorescence of FITC channel, collecting 10,000 events per sample. (B) HEK 293T cells were challenged with YPIIIΔyopHMOJE (YPIIIΔ5) or YPIII ∆yopB (YPIIIΔB) at MOI = 25 for 2 h. Cells were labeled with FITC LIVE/DEAD stain and analyzed by flow cytometry to determine extent of pore formation (Materials and Methods). (C) CD59 KO 293T cells were transfected with a plasmid expressing human CD59 and stable monoclonal cell lines were obtained with CD59 levels that were similar to endogenously expressed protein (WT1 and WT2) or which were overexpressed (OE1 and OE2). The histogram indicates the level of FITC-conjugated α-human CD59 labeling for the WT, CD59 KO, and pCD59 clones as determined by flow cytometry. (D) Indicated cell lines were challenged at MOI = 25 for 2 h with YPIIIΔ5 (See Supplemental Figure S2A for YPIIIΔB control). Cells were labeled with FITC LIVE/DEAD stain and analyzed by flow cytometry to determine extent of pore formation. (See Supplemental Figure S2B for pore formation peak data showing WT1, WT2, OE1, and OE2 compared to WT and KO after infection by YPIIIΔ5). Data are geometric mean ± SEM of the fluorescence intensity normalized to WT Results represent three independent experiments performed in technical triplicate. Statistical significance was calculated using a one-way ANOVA with Dunnett’s multiple comparison test (*p < 0.05).

To determine if Yptb challenge of the CD59 KO cell line exhibited translocation defects similar to those observed in the shRNA knockdown, a T3SS pore formation assay was performed. Once injected into a target cell, the Yop effectors downmodulate pore formation to prevent immediate cytotoxicity of the host29. Therefore, a ΔyopHMOJE (YPIIIΔ5) strain that lacks all regulatory Yops and exhibits hyper pore-forming activity was used to measure pore formation, measuring fluorescence of an amine-reactive membrane-impermeant probe as a proxy17.

The Yersinia translocon pore complex comprises the two hydrophobic pore proteins YopB and YopD, along with the hydrophilic scaffolding protein LcrV, which localizes to the needle tip7. A yopB mutant strain (YPIIIΔB), lacking the major translocon pore protein YopB, is unable to form pores in the host cell plasma membrane and serves as a negative control for pore formation and translocation10. WT and CD59 KO cells were challenged with YPIIIΔB or YPIIIΔ5 at MOI = 25 for 2 h and analyzed for FITC incorporation by flow cytometry. WT and CD59 KO cells infected with the YPIIIΔB mutant were intact and unperturbed, as shown by their similarly low background fluorescence (Fig. 1B). In WT cells infected with YPIIIΔ5, two distinct right-shifted populations labeled by the probe were observed. The peak furthest to the right indicates maximum cytotoxicity, while the wider, shouldered peak represents varying degrees of pore formation. The CD59 KO cells also showed two populations, but there was a distinct leftward shift toward lower probe incorporation, indicating that cells lacking CD59 were less susceptible to pore formation by YPIIIΔ5 than WT cells (Fig. 1B). Similar results were found using a real-time propidium iodide permeability assay (Supplemental Fig. S1).

To further interrogate the effect of CD59 plasma membrane levels on Yptb T3SS function, WT CD59 was introduced into the CD59 KO cell line to evaluate if pore-forming activity could be restored. Human CD59 expressed from the mammalian expression vector pcDNA3.1 + was transfected into CD59 KO 293T cells, and monoclonal populations were isolated after antibiotic selection. Two clones exhibiting CD59 levels similar to WT (KOpCD59-WT1 and KOpCD59-WT2), as well as two clones with increased surface levels of CD59 (KOpCD59-OE1 and KOpCD59-OE2) were identified (Fig. 1C). Each of these clones, along with the WT and KO cell lines, was assayed for pore formation after infection by YPIIIΔ5. Interestingly, both CD59 clones with increased surface levels of CD59 showed similar resistance to pore formation by YPIIIΔ5 compared to what was observed with the KO cells. The only clone that restored the degree of pore formation seen in WT cells was one of the clones that exhibited WT levels of surface CD59 (Fig. 1D; WT1). Although clones could be isolated that restored pore formation by YPIIIΔ5, there appeared to be confounding effects that prevented effective complementation. In addition to the clones shown here, random screening of several clones that overproduced CD59 relative to WT failed to show the same level of pore formation as the WT1 clone (Fig. 1D).

Phenotypic variation was observed among the CD59 KO and KOpCD59 clones after prolonged passaging, introducing another confounding factor. Strategies were sought to overcome this issue. CD59 is one of the most abundant GPI-linked proteins, so knocking it out may select for suppressor mutations or unpredictable changes in regulatory patterns that could be propagated over many passages. For this reason, we continued investigating the role of CD59 in Yptb T3SS function using transient siRNA knockdown. Efficient CD59 knockdown was achieved 72 h post-transfection using mixed pools of siRNAs directed against CD59 (Materials and Methods; Fig. 2A).

Fig. 2.

Fig. 2

Knockdown of host cell CD59 inhibits translocation of T3SS substrates during Yptb infection. WT 293T cells were transfected with either human CD59 siRNA or non-targeting control siRNA to knock down CD59 expression. Assays were performed after 72 total hours of transfection. (A) Cells were probed with FITC-conjugated α-human CD59 and analyzed by flow cytometry for cell surface localization of CD59. Bars note the fluorescence distribution of siCD59 sample. (B), (C) Approximately 2.5 × 105 siRNA transfected cells were seeded overnight. Cells were challenged with YPIII/YopE-TEM or YPIIIΔyopB/YopE-TEM at MOI = 1 for 1 h. Infected cells were harvested, loaded with CCF4-AM and analyzed by flow cytometry. (B) Contour plots displaying the fluorescence intensity of the blue channel (450nm), indicative of YopE translocation, vs. the green channel (515nm) displaying all cells. (C) Translocation was calculated as the geometric MFI ratio for the 450/515 channels. Data shown are a representative experiment (from 3 independent experiments performed in technical triplicate). Statistical significance calculated using two-way ANOVA with Dunnett’s multiple comparison test. Not significant: ns; p < 0.0001: ****; p < 0.05: *.

To evaluate siCD59 knockdown populations using a strategy that does not require loss of membrane integrity or causing cell lethality, T3SS function was assessed by measuring Yop translocation into host cells, detected by assaying for YopE-TEM (or YPIIIΔB YopE-TEM) translocation using a β-lactamase reporter strain followed by FACS analysis30. After a 1h infection at MOI = 1, HEK 293T cells were loaded with CCF4-AM, a FRET-based β-lactamase substrate that readily enters the host cells, as detected by a green fluorescence signal at 515 nm after 409 nm excitation. Translocation of YopE-TEM was detected by cleavage of the TEM substrate, which results in a blue fluorescence signal at 450 nm, visualized as the 450 nm emission relative to 515 nm after 409 nm excitation. This was displayed with contour plots of the blue vs. green channels (Fig. 2B). Green cells were gated with the YPIIIΔB YopE-TEM negative control (Fig. 2B, left panel). After a 1h infection of siNT cells with YopE-TEM, approximately 65% of the gated blue vs. green cells shifted to the blue gate, indicating robust translocation (Fig. 2B, middle panel). In the siCD59 infection (Fig. 2B, right panel) this was reduced to 45% of the gated cells, with no detectable translocation in almost 32% of the cells. The total translocation in the population was also reduced by about 50%, as indicated by the ratio of the total fluorescence intensities at 450 nm and 515 nm in siCD59-knockdown cells from triplicate samples (Fig. 2C).

Host cell CD59 indirectly supports Yptb T3SS-dependent pore formation

Because pore formation is defective in the CD59 mutant, this protein could act as a receptor for the T3SS channel, so a pair of experiments was performed to test this model. First, a receptor-blockade strategy was employed. Intermedilysin (ILY) is a bacterial-encoded cholesterol-dependent pore-forming toxin (PFT) from Streptococcus intermedius that requires CD59 as a receptor22. The wild-type form of this protein (ILYWT) forms pores in the host cell membrane, whereas a mutant version that is fixed in a prepore conformation (ILYPP) binds CD59 without forming an active pore, leaving the host cell membrane intact31. The Yptb translocon pore proteins YopB and YopD share physiological properties with PFTs32, and we hypothesized that if the Yptb translocon pore interacts with CD59 similarly to ILY, then ILYPP binding to CD59 will block T3SS-dependent pore formation.

His-ILYWT and His-ILYPP were expressed in E. coli BL21 (DE3) and purified (Materials and Methods). HEK 293T cells were pretreated with ILYPP or mock buffer, challenged with ILYWT, and assayed for pore formation. Cells that were mock-treated and challenged with ILYWT exhibited high levels of pore formation, confirming that the ILYWT was functioning properly (Fig. 3A). Cells pretreated with ILYPP were protected from pore formation, indicating that the mutant protein successfully bound the CD59 receptor and blocked ILYWT (Fig. 3A). To determine if ILYPP could block Yptb T3SS-dependent pore formation, 293T cells were pretreated with ILYPP for 1 h and then challenged with YPIIIΔ5 or YPIIIΔB at MOI = 25 for 2 h (Fig. 3B). There was no difference in pore formation among the ILYPP pretreated and mock-treated cells, indicating that if there was a direct interaction between CD59 and the T3SS machinery, it did not occur at the ILY binding site.

Fig. 3.

Fig. 3

Host cell CD59 indirectly supports YPIII T3SS-dependent pore formation. (A), (B) ILYPP treatment effectively blocks binding and subsequent pore formation by ILYWT. WT 293T cells were seeded overnight in 12-well plates. Cells were pretreated with 100nM of ILYPP or buffer for 1 h, challenged with either 30nM ILYWT (A) or YPIIIΔ5 or YPIIIΔB at MOI = 25 (B) and incubated for 2 h. Cells were harvested and assayed for pore formation. Results shown in panels A and B represent the mean from three independent experiments in technical duplicate or triplicate, and all pore formation data were normalized to untreated 293T cells challenged by YPIIIΔ5. (C) WT HEK 293T cells were seeded overnight in 12-well plates. Cells were treated with phospholipase C (PLC) and incubated at 37°C, 5% CO2 for 30 min before harvesting and labeling with FLAER for detection of GPI-linked proteins by flow cytometry. (D) WT HEK 293T cells were seeded overnight in 12-well plates and pretreated with PLC or buffer prior to challenge with YPIIIΔ5 or YPIIIΔB at MOI = 25 for 2 h. Cells were then harvested and assayed for pore formation. Data are geometric means ± SEM of MFI after subtraction of uninfected control cell background and normalized to untreated 293T cells challenged by YPIIIΔ5. Results represent three independent experiments done in technical duplicate or triplicate. Statistical significance was calculated using an unpaired two-tailed Welch’s t test (Not significant: ns; p < 0.0001: ****).

A second assay was then performed to determine if CD59 acts as a receptor for the T3SS translocon. To eliminate the possibility that an insufficient quantity of ILYPP was added to the cells to block all binding sites, cells were treated with phospholipase C (PLC), an enzyme that cleaves above the phosphoinositol group of the GPI-anchor, releasing CD59 and other GPI-linked proteins. WT 293T cells were pretreated with PLC, challenged with YPIIIΔ5, then assayed for pore formation. This strategy depleted GPI-linked proteins based on detection of these linkages with Alexa488-conjugated proaerolysin, as PLC treatment resulted in a distinct decrease in fluorescence compared to the mock-treated cell population (Fig. 3C). PLC-treated cells were also labeled with FITC-conjugated α-human CD59 to confirm that there was effective removal of CD59 from the cell surface (Supplemental Fig. S3). After the 2 h infection with YPIIIΔ5, there was no significant difference in pore formation between the PLC-treated and mock-treated cells (Fig. 3D). This provides clear evidence that CD59 is not a receptor for T3SS translocation, and additionally rules out any other GPI-linked protein for this potential receptor role.

CD59 is required for efficient focal adhesion disruption by Yersinia

Upon contact with host cells, the bacterial invasin and YadA proteins engage and activate host β1-integrin receptors, leading to recruitment of signaling and cytoskeleton-binding proteins such as paxillin, focal adhesion kinase (FAK), Src-family kinases, and p130Cas. These protein complexes at the integrin cluster sites are called focal adhesions33. Lipid raft domains are also recruited and involved in integrin clustering and likely promote the assembly and reinforcement of focal adhesions (FAs)34. Yersinia can disrupt these FAs by translocating the YopH protein tyrosine phosphatase, blocking phosphotyrosine signaling and the actin rearrangements that drive phagocytosis35–37. YopH has many host targets, including FAK, p130Cas, and Src-family kinases at focal adhesion sites33,38,39, as well as the tyrosine kinase Lck and the LAT adapter in T cells36,40.

To determine whether CD59 activates focal adhesion formation40, an anti-phosphotyrosine (pTyr) antibody was used to quantify maintenance of focal adhesions after challenge with the WT Yptb strain. To this end, HeLa cells were knocked down with either siCD59 or the siNT control for 72 h (See Supplemental Fig. S4), challenged with Yptb gfp+ bacteria, fixed, and immunostained with anti-pTyr. Focal adhesions appeared as brightly stained fiber-like bundles, numerous in both siCD59 knockdown and siNT control cells in the absence of infection (Fig. 4A). In contrast, upon challenge with WT Yersinia, focal adhesions were readily disassembled in CD59-positive siNT control cells, as evidenced by the absence of large bundles and the increased number of puncta (Fig. 4B, left panel). This process was inefficient in the siCD59 knockdown cells, as larger focal adhesions were still visible (Fig. 4B, right panel) compared to the siNT control cells.

Fig. 4.

Fig. 4

CD59 depletion lowers focal adhesion disruption by Yptb. HeLa cells were transfected with either siCD59 or the siNT control for 72 h. Cells were challenged with Yptb gfp + at an MOI = 5 by 5 min centrifugation at 200xg followed by immediate washing and fixing. The cells were then immunostained with anti-pTyr followed by probing with anti-mouse-AF594, and nuclei were stained with Hoechst (1:10,000). (A) Focal adhesion staining with anti-pTyr of uninfected cells. (B) Cells challenged with Yptb gfp + . Scale bar = 10μm. Focal adhesions were identified and measured as described (Materials and Methods). (C), (D) Average size and total area displayed. Data analyzed using Ordinary One Way ANOVA followed by Sidak’s test (*p < 0.05).

Focal adhesions were identified and measured by an image analysis routine that distinguishes edges, based on a previously published workflow41. The average size of each focal adhesion and the total sum of pixels identified per cell were significantly lower in CD59-positive control cells compared to the CD59 knockdown after bacterial infection (Fig. 4C and D, respectively), indicating that CD59 is required for efficient disruption of these host cell signaling assemblies. This is consistent with a defect in YopH accumulation and/or targeting of focal adhesions after bacterial contact with host cells deficient for CD59.

Depletion of CD59 alters GM1 trafficking after Yptb challenge

Our results indicate that the Yptb T3SS is sensitive to alterations in cellular CD59 content. CD59 is enriched in microdomains in the cell membrane where cholesterol, glycosphingolipids, GPI-linked proteins, and signaling proteins are densely associated24. These receptor-rich microdomains are thought to be highly dynamic and may transiently rearrange in response to activating signals, such as pathogen adhesion42. As CD59 plays an indirect role in supporting Yptb-dependent T3SS function (Fig. 3), the dynamics of glycosphingolipid GM1 organization were investigated as a function of CD59 expression. Cholera toxin B subunit (CtxB) binds to GM1 in lipid microdomains and can be used to detect altered distribution in response to bacterial binding43. Therefore, the GM1 probe AlexaFluor594-CtxB was added to the cell culture medium immediately before Yptb challenge of cells that had been siRNA-depleted of CD59 for 72 h prior to infection, using nontargeting siRNA as the control (siCD59 and siNT respectively; See Materials and Methods and Fig. 5G).

Fig. 5.

Fig. 5

CD59 knockdown affects localization of the lipid raft marker GM1. HeLa cells were transfected for 72 h with 25nM of siCD59 or non-targeting siRNA, then seeded on glass coverslips for 24h prior to bacterial challenge. (A), (B) Uninfected. (C), (D) Cells challenged with YPIIIΔB(pGFP). (E), (F) Cells challenged with YPIII-WT(pGFP). Infections were performed at MOI = 5 in presence of CtxB-AlexaFluor594. Bacterial-host cell contact was initiated by 5 min centrifugation at 200xg followed by immediate washing and incubation with α-Ctx. Cells were fixed with 4% PFA, and nuclei stained with Hoechst (1:10,000). Scale bar = 10μm. (G). Depletion with siCD59 results in reduced CD59 surface expression compared to control. HeLa cells were depleted with either siCD59 (blue) or siNT (red) for 72 h, fixed, probed with anti-CD59 and subjected to flow cytometry to detect surface localization of CD59. Bars note the fluorescence distribution of siCD59 sample. (H). Depletion of CD59 blocks polar localization of CtxB proximal to cell nucleus. Polarization Index was determined as described (Materials and Methods; Supplemental Fig. S5) from images of the six conditions described (A)–(F). Bar: Median of each noted sample. Statistics: Kruskal–Wallis multiple comparisons.

In siNT controls, GM1 was localized in puncta as well as to one side of the perinuclear region (Fig. 5A). After CD59 depletion (Fig. 5G), however, GM1 puncta accumulated at the cell periphery when compared to the siNT control cells, with reduced polar distribution proximal to the nuclei (compare Fig. 5A, B, two examples). Challenge with the T3SS-deficient Yptb ΔB mutant showed similar results to the uninfected controls (compare Fig. 5D–B). Strikingly, when siNT cells were challenged with WT Yptb, any residual peripheral localization was largely lost and GM1 was almost exclusively localized in a polar fashion proximal to the nucleus (Fig. 5E). In stark contrast, infection of CD59 knockdown cells with WT Yptb resulted in little, if any, polar staining about the nucleus, with GM1 puncta dispersed across the whole cell (Fig. 5F), consistent with a defect in GM1 trafficking.

To quantify the CD59-dependent polar staining proximal to the nucleus, an intensity-weighted circular resultant length index was determined for the GM1 localization data (Materials and Methods; Supplemental Fig. 5). To this end, a 1μm wide band about the circumference of each nucleus was determined as a region of interest, with the relative polarization of CtxB localization quantified and expressed as a Polarization Index (R; Fig. S5A-D). Uniform circumferential distribution of CtxB was defined as the Polarization Index R = 0, while 100% polar localization was set to R = 1.0 (Fig. S5, panel E). Using this index, siCD59 quantitatively blocked polar perinuclear trafficking of GM1 relative to siNT control under all conditions tested (Fig. 5H; P < 0.0001 for each condition, Kruskal–Wallis multiple comparisons). Also in a quantitative fashion, challenge of cells with YPIII WT increased the polar perinuclear localization of GM1 relative to uninfected controls (P = 0.0002), and this trafficking was dependent on the presence of CD59 (Fig. 5H; P < 0.0001). Therefore, the absence of CD59 caused the dispersion of GM1 gangliosides and blocked stimulation of polar localization in response to the challenge of WT Yptb. This phenotype was not due to alterations in the surface localization of GM1 gangliosides, as flow cytometry of cells probed for GM1 indicated that CD59 knockdown did not affect GM1 surface levels compared to siNT control cells (Figure S6). Therefore, loss of CD59 function resulted in diffuse punctate localization of GM1 and failure of GM1 to traffic to a polar perinuclear locale.

Loss of CD59 perturbs lipid composition of plasma membrane

To investigate if the loss of CD59 results in changes of lipid composition, HEK 293 T WT and CD59-KO cells were extracted in 2:1 chloroform:methanol, and samples were analyzed by LC–MS/MS to identify lipid components44. Principal component analysis (PCA) of mass spectrometry peak data normalized by percent abundance within each sample showed suitable separation of samples by cell line (Fig. 6A). The two most abundant lipid classes in both lines were phosphatidylcholine (PC) and phosphatidylethanolamine (PE). The bulk sum carbon (C) composition of the acyl chains for PC species detected by LC–MS/MS is shown in Fig. 6B, indicated by total number of carbons as a percentage sum of all PC lipids for each sample. Acyl chain content species totaling 34 bulk sum carbons was by far the most abundant PC, and the WT had significantly more of these species compared to CD59 KO cells (P < 0.05). Interestingly, the KO cells exhibited a greater number of lower (32 carbons) and very large acyl chain content species (> 40 bulk sum carbons) (Fig. 6B). A similar trend was found in PE species (Fig. 6C). WT cells had more of the most abundant 36C content species among PE, while greater numbers of larger (38C) and smaller (< 35C) species were detected in CD59KO cells compared to WT cells (Fig. 6C).

Fig. 6.

Fig. 6

CD59 KO alters cellular lipid composition. Lipids were extracted from HEK 293 T WT and CD59 KO cells (Materials and Methods). Representative results of two independent experiments performed in triplicate. (A) Knockout of CD59 alters lipid profile. Principal component analysis (PCA) of CD59 KO vs WT cells. Data was normalized by percent abundance within each sample. (B) Sum of carbon counts of PC acyl species as a percentage of total PC within each sample. (C) Sum of carbon counts of PE acyl species as a percentage of total PE within each sample. (D) Saturation levels of SM lipid species as a percentage of total SM within each sample. (B)–(D) Significance determined by unpaired t test using two-stage step-up with FDR of 1% for multiple comparisons, *p < 0.000001. (E) Alteration of lipid flux as a consequence of loss of CD59. Lipid peak data normalized by percent abundance was analyzed using LIPIDMAPS BioPan software, available through LIPIDMAPS.org47. Lipid subclass pathways displayed were found to be similarly altered in both experiments. Abbreviations: PC, phosphatidylcholine; PE, phosphatidylethanolamine; SM, sphingomyelin; PS, phosphatidylserine; DG, diacylglycerol; LPS, lysophosphatidylserine.

Sphingomyelin (SM) is enriched in ordered lipid raft domains and has been found to preferentially organize with CD59 within the plasma membrane45. Increased unsaturation of SM results in greater area and decreased lateral diffusion rates of the lipid46. There was a significantly higher percentage of SM(36:2) (36 acyl carbons, 2 total double bonds) in CD59 KO compared to WT cells (Fig. 6D). The increased unsaturation in the SM 36C species may cuase less-ordered membrane dynamics, potentially affecting lipid raft organization and the ability to coalesce in a perinuclear locale after bacterial contact (Fig. 5). CD59 KO also altered flux through several lipid biosynthesis and catabolic pathways, with similar directionality across two independent experiments, as analyzed using the LIPIDMAPS BioPan software tool (Fig. 6E)47. The results of this analysis indicate that in the absence of CD59, there is increased accumulation of phosphatidylcholine (PC) lipids at the expense of phosphatidylserine (PS) and lysophosphatidylserine (LPS) lipids. This should result in membranes becoming less negatively charged in the mutant (PC vs. PS and LPS), while the reduction in lysophosphatidylserine could interfere with trimeric G protein signaling via G protein-coupled receptors48,49. Altogether, these results indicate that the absence of CD59 alters the homeostatic maintenance of lipid species composition in the host cell.

Discussion

In this study, we found that host cell CD59 is required for efficient function of the Yersinia pseudotuberculosis type III secretion system (T3SS). Cells lacking CD59 exhibited reduced T3SS-mediated pore formation following bacterial contact, as well as reduced translocation of Yop effector proteins into host cells. Extracellular blockade of CD59 did not impair either pore formation or effector translocation, indicating that CD59 is unlikely to serve as a direct receptor for the T3SS. Furthermore, enzymatic removal of all surface-exposed GPI-anchored proteins before infection did not reduce Yptb(Δ5)-dependent pore formation. These data, together with the inability of the CD59-binding protein ILYPP to block the T3SS machinery, collectively indicate that CD59 is unlikely to directly interact with pathogen components. Instead, CD59 appears to facilitate T3SS translocon assembly or function through an indirect mechanism acting after bacterial attachment to the host cell.

Host focal adhesion (FA) complexes are important host cell signaling hubs targeted by the tyrosine phosphatase YopH, which disassembles them and helps prevent bacterial phagocytosis. We found that CD59 facilitates efficient focal adhesion disruption by Yptb (Fig. 4). In cells depleted of CD59, focal adhesions were larger, on average, and occupied a greater total area per infected cell than in control cells, indicating reduced FA disassembly. One likely explanation is that CD59 depletion reduced delivery of YopH into host cells. We previously showed that loss of CD59 decreases YopH translocation by more than 80% relative to control cells17. Consequently, less intracellular YopH would be available to disrupt focal adhesions. A second alternative possibility is that CD59 influences host signaling pathways that contribute to focal adhesion dynamics. CD59 has been implicated in signaling pathways involving Src-family kinases, including Lyn, Fyn, and Lck, some of which interact with focal adhesion kinase (FAK)18,40,50. CD59 may therefore help recruit or activate these signaling molecules at sites of bacterial attachment. As CD59 is a well-established component of lipid rafts, which are membrane microdomains that participate in integrin clustering and focal adhesion assembly34, loss of CD59 could stabilize focal adhesions or impair their normal remodeling. Finally, the effects of CD59 loss may extend beyond host-cell signaling. Its loss may interfere with Yop localization, preventing access to signaling structures normally targeted by the Yops.

Previous studies indicate that the T3SS translocon may interact with lipid raft components. The chemokine receptor CCR5 was identified as a host factor that contributes to efficient Yersinia pseudotuberculosis (Yptb) T3SS function17. CCR5 belongs to the same family of G protein-coupled receptors (GPCRs) as Fpr1, which was recently identified as a receptor required for efficient Yersinia pestis infection17,50. Notably, depletion of CCR5 reduced but did not eliminate translocation of Yptb T3SS effectors. This observation is consistent with Yptb utilizing additional membrane components that partially compensate for CCR5 loss. Such functional redundancy contrasts with the apparently more critical role of Fpr1 during Y. pestis infection. Interestingly, chemokine receptors are known to colocalize with membrane raft markers such as GM151. A similar T3SS-wielding pathogen, Pseudomonas aeruginosa, was found to preferentially bind the host receptor glycosphingolipid globotriaosylceramide (Gb3), and depletion of either flotillin or CD59, both found in raft nanodomains with Gb3, reduced uptake of P. aeruginosa52. Furthermore, functional lipid rafts are important for adhesion and T3SS function in Shigella, EPEC, and Salmonella25–27. These findings indicate that the organization of various host proteins into structured membrane regions may provide the most efficient target for Yersinia to dock, form pores, and deliver Yops via the T3SS.

We examined whether CD59 affected ganglioside-rich domains by challenging cell with fluorescently labeled cholera toxin B subunit (CtxB). In uninfected cells, this marker for GM1 was predominantly trafficked to the perinuclear region in the presence of CD59. When CD59 was depleted, there were noticeably more CtxB puncta visible around the cell periphery, while infection with WT Yptb markedly enhanced the peripheral localization of GM1 puncta in si-NT control cells. Accumulation of the GM1 marker was easily detected in the perinuclear region in host cells transfected with the si-NT control, while this perinuclear localization was completely lost in si-CD59 knockdown cells after contact with WT Yptb. CD59 may play a role in mobilizing GM1 to the perinuclear region through endocytosis, plasma membrane rearrangements, or recycling of this marker back to the plasma membrane.

Binding of cholera toxin B subunit (CtxB) to GM1 triggers receptor-mediated endocytosis, followed by retrograde trafficking from the plasma membrane through the trans-Golgi network toward the endoplasmic reticulum. This trafficking pathway is commonly detected microscopically as perinuclear accumulation of CtxB-bound GM1, consistent with the localization observed in cells expressing normal levels of CD5951. Following internalization, GM1 can also enter recycling pathways, in which it is sorted into endosomal compartments and subsequently returned to the plasma membrane. Early stages of this process are visualized as punctate intracellular structures, whereas later stages are associated with accumulation in pericentriolar recycling endosomes52,53. The absence of CD59 may shift how host endocytic pathways are utilized after Yptb engagement, favoring a blockade after puncta formation. This could result from changes in the plasma membrane that either prevent effective engagement of the T3SS machinery, alter trafficking of bacterial effectors, or prevent hijacking of host factors by bacterial effectors. Obviously, under CD59 depletion conditions, there must be some low-level or improperly functioning activity of the T3SS that exacerbates the inability of the CtxB-engaged GM1 to coalesce in a perinuclear locale in the absence of CD59.

The specific lipid composition of the host cell plasma membrane can affect its structure, function, and interactions with pathogens, with PC and PE being the two most abundant lipid classes. PC is a cylindrical-shaped lipid that allows tight packing of lipids and is present in higher concentrations along with sphingolipids in the outer leaflet of the plasma membrane relative to the inner leaflet54,55. In contrast, PE, phosphatidylserine (PS), and phosphatidylinositol (PI) are predominantly localized to the inner leaflet of the plasma membrane52. The physical behavior of membranes is also influenced by the length and saturation of lipid acyl chains53. In general, lipids with longer and more saturated acyl chains tend to increase membrane thickness and reduce membrane flexibility, making membranes more resistant to deformation or bending56. In our lipidomic analysis, PC species containing a total acyl-chain length of 34 or 36 carbons (denoted PC 34C and PC 36C) were the most abundant PC species detected in wild-type (WT) cells. Compared with WT cells, CD59 knockout (KO) cells contained lower proportions of these 34C and 36C PC species and higher proportions of PC species with longer total acyl-chain lengths, particularly those exceeding 40 carbons (Fig. 6B). A similar pattern was observed for PE species. PE molecules with a total acyl-chain length of 36 carbons were among the most abundant PE species in WT cells. In CD59 KO cells, the abundance of these 36C PE species was reduced, whereas PE species containing either shorter or longer total acyl-chain lengths were increased relative to WT cells (Fig. 6C). These results indicate that loss of CD59 is associated with a shift in membrane phospholipid composition away from the predominant intermediate-chain PC and PE species found in WT cells and toward a broader distribution of shorter- and longer-chain lipid species. Such changes may alter membrane thickness, fluidity, curvature, or organization, potentially affecting host–pathogen interactions and membrane-associated cellular processes.

Acyl chain saturation is also a determinant of plasma membrane organization and fluidity. Fully saturated GM1 C16:0 species have been shown previously to co-cluster with CD59, while C16:1 species do not57. Our analysis showed that SM C36:2 acyl chains were increased in CD59 KO cells compared to WT cells (Fig. 6D). The increased levels of unsaturation could affect membrane fluidity, raft formation, or lipid-protein interactions. BioPAN analysis revealed altered flux through various catabolic and metabolic pathways, indicating that CD59 is associated with proper lipid homeostasis and plasma membrane maintenance (Fig. 6E).

In this study, we have shown that CD59 is required for efficient pore formation and translocation of bacterial effectors via the Yptb T3SS. The depletion of CD59 revealed changes in the localization of lipid raft marker GM1, indicating a large-scale disruption of membrane dynamics. CD59 is an important structural component of raft domains, and it is possible that when cells lack this abundant GPI-linked protein, the formation, stability, and/or mobility of these domains is disrupted. More than one mechanism may explain this relationship. Disrupted lipid raft organization may disturb lipid-dependent signaling pathways that normally support efficient T3SS activity. Alternatively, disruption of raft domains could impair interactions between bacterial T3SS components and host signaling proteins, including kinases involved in signal transduction. Either mechanism, or a combination of both, could reduce efficient translocon assembly, pore formation, or effector delivery. Future work will focus on determining if other host components involved in lipid raft signaling play critical roles in T3SS function, as well as on identifying the critical step in the T3SS translocator insertion process that requires intact CD59.

Materials and methods

Bacterial strains and cell culture conditions. All Y. pseudotuberculosis strains used are derivatives of YPIII (wildtype) and were generously provided by Joan Mecsas (See Table 1). HEK 293 T cells (ATCC) and HeLa cells (ATCC) were maintained in Gibco DMEM + 10% fetal bovine serum and incubated at 37 °C, 5% CO2.

Table 1.

Bacterial strains used in this study.

Background Strain References
YPIII YPIIIΔyopB YPIIIΔB) 10
YPIII YPIIIΔyopHMOJE (YPIIIΔ5) 10
YPIII YPIII E-TEM 66
YPIII YPIII gfp +  67
YPIII YPIIIΔyopB gfp +  67

T3SS induction. Single colonies of indicated Yptb strains were picked from agar plates and grown in 2xYT broth overnight on a rotator at 26 °C. Overnight cultures were diluted to A600 = 0.200 in induction media (2xYT + 20 mM MgCl2 + 20 mM Na2C2O4), rotated at 26 °C for 1.5 h, then moved to 37 °C and rotated for 1.5 h to induce expression of the T3SS prior to all infection assays.

Generation of CRISPR CD59 knockout 293 T cells. Stable monoclonal CD59 KO HEK 293 T cells were generated using the LentiCRISPRv2 vector (a gift from Feng Zhang, Addgene plasmid #52,961)28 targeting the 20 bp sequence 5’ ACGACGTCACAACCCGCTTG 3’ of the human CD59 coding region. Oligonucleotides containing this targeted region plus 5’ BsmBI restriction sites (sense: CACCGACGACGTCACAACCCGCTTG and antisense: AAACCAAGCGGGTTGTGACGTCGTC) were annealed and ligated into the LentiCRISPRv2 plasmid at the BsmBI digestion site. The sgRNA-containing vector was linearized within the ampicillin cassette and transfected into WT 293 T cells. After 48 h transfected cells were selected under puromycin and clonal populations were isolated, outgrown, and successful knockout determined using fluorescent antibody labeling and FACS analysis as described below. One knockout clone was used for all subsequent experiments, including the generation of clonal cell lines with wildtype and high levels of CD59 surface expression.

Generation of CD59 complement and overexpressing 293 T cell lines. 2 × 105 WT or CD59 KO HEK 293 T cells were seeded in 6-well tissue culture-treated plates and the pcDNA3.1 Hygro + (empty vector) or pcDNA3.1 Hygro + hCD59 plasmids were transfected using Lipofectamine 2000 (Invitrogen). Hygromycin was added after 48 h to select for transfected cells, and transfectants were single-cell sorted into 96-well plates containing conditioned cell media. Arising clonal populations were maintained with Hygromycin B to select against loss of the integrated plasmid.

Translocation assay. Approximately 2.5 × 105 HEK 293 T cells were seeded in tissue culture-treated 24 well dishes overnight. YPIII E-TEM or YPIIIΔyopB E-TEM were grown in induction conditions (See T3SS induction above), diluted in prewarmed DMEM including 10% FBS, and added to 293 T cells at an MOI = 1. The infection plates were centrifuged for 5 min at 1000 rpm to maximize bacterial contact with cells and incubated at 37 °C, 5% CO2, for 1 h. Cells were then harvested in 180 μl of PBS. A 10X solution of CCF4-AM reagents was prepared in PBS (LiveBLAzer™ FRET—B/G Loading Kit with CCF4-AM, Invitrogen)58, 20μL was added to each sample tube, briefly vortexed, and incubated for 20 min protected from light at room temperature. Samples were then analyzed on a BD FACS Calibur and data was processed with FlowJo (Tree Star) software, with 10,000 events collected for each sample. Translocation was quantified by subtracting background signal present in uninfected cells and calculating the ratio of the geometric mean fluorescence intensity of the 450/515 channels.

Pore formation assay. Approximately 2.5 × 105 HEK 293 T cells were seeded in tissue culture-treated 24-well dishes overnight. Overnight bacterial cultures of YPIII ΔyopHMOJE (YPIIIΔ5) or YPIIIΔyopB (YPIIIΔB) were grown in T3SS induction conditions prior to infection (See T3SS Induction). Induced YPIIIΔyopHMOJE or YPIIIΔyopB were diluted in prewarmed DMEM + 10% FBS and added to HEK 293 T cells at an MOI of 25. After challenge, plates were centrifuged for 5 min at 200xg and incubated at 37 °C, 5% CO2 for 2 h. The contents of each well were removed by pipetting the cells up and down, washing with Hanks’ balanced salt solution (HBSS), Gibco, resuspending in Live/Dead dye diluted 1:1000 in HBSS (LIVE/DEAD™ Fixable Green Dead Cell Stain Kit, Molecular Probes, Life Technologies), and incubated for 30 min protected from light. Cells were washed twice in HBSS containing 1% Bovine Serum Albumin (BSA), resuspended in 0.300 mL HBSS, and analyzed by flow cytometry on a BD LSRII flow cytometer. At least 10,000 events were collected per sample. Pore formation was quantified by determining the geometric mean of the FITC channel. Data was processed with FlowJo (Tree Star) software.

CD59 and GPI-linked surface protein detection. Flow cytometry was utilized to determine the levels of CD59 and GPI-linked proteins on the host cell surface. Live HEK 293Ts cells were washed with PBS, blocked on ice in PBS containing 0.5% BSA for 10 min, and pelleted for 5 min at 300rcf. For CD59 detection, cells were resuspended in mouse anti-human CD59-FITC (BD Pharminogen, clone p282 (H19)), diluted 1:500 in blocking buffer. To detect GPI-linked proteins, cells were resuspended in fluorescently labeled proaerolysin (FLAER, Alexa 488 variant, CedarLane Labs) diluted 1:20 in blocking buffer. Cells were incubated on ice protected from light for 30 min, washed once in blocking buffer, resuspended, and transferred to a round bottom polystyrene 12 × 75 mm tube for flow cytometry analysis. When fixation was required, cells were washed in PBS, fixed for 20 min in PBS containing 4% paraformaldehyde (PFA) at RT, protected from light, washed 3 × in PBS, blocked for 1 h in 4% BSA, resuspended in either anti-CD59 or FLAER (1:500 or 1:20, respectively) for 1 h rotating at 37 °C, washed once, resuspended in blocking buffer, then transferred to round bottom 5 mL polystyrene tubes for flow cytometry analysis.

CD59 siRNA knockdown. HEK 293 T or HeLa cells were seeded in 6-well tissue culture-treated plates overnight. 25 pmol per well of siGENOME SMARTPOOL human CD59 siRNA (Horizon Discovery) or 25 pmol of non-targeting control siRNA were transfected using Lipofectamine RNAiMax (Invitrogen). After 48 h, cells were lifted and seeded in 24-well tissue culture plates. Cells were then challenged with induced YPIII strains after a total of 72 h of siRNA knockdown.

Phospholipase C treatment. 5.0 × 105 HEK 293T cells per well were seeded into 12-well tissue culture-treated plates overnight. Overnight cultures of YPIII ΔyopHMOJE or YPIIIΔyopB were then diluted and induced (see T3SS induction). To cleave surface GPI-linked proteins from HEK 293Ts cells, 0.1U of phospholipase C protein (Phosphatidylinositol-Specific from Bacillus cereus, Invitrogen), or an equivalent volume of buffer was added to each well 30 min prior to infection and incubated at 37°C, 5% CO2, then cells were infected at MOI = 25. Plates were centrifuged for 5min at 200xg and incubated at 37°C, 5% CO2 for 2 h. Following infection, cells were either assayed for pore formation or probed with FLAER to determine levels of GPI-linked proteins present on the host cell surface.

Expression and purification of intermedilysin proteins. Plasmid constructs for protein expression of His-tagged WT intermedilysin (His-ILYWT) and a prepore conformation mutant (His-ILYPP) were generously provided by Rodney K. Tweten59. E. coli BL21 (DE3) cultures harboring either the His-ILYWT or His-ILYPP plasmids were grown overnight in LB broth supplemented with 100ug/mL carbenicillin. Overnight cultures were diluted 1:100 in LB and incubated with agitation at 37 °C until they reached an A600 = 0.8, supplemented with 100ug/mL carbenicillin, and induced by adding 1 mM IPTG (final concentration). Cultures were incubated at room temperature overnight and pelleted at 5000 rpm for 20 min at 4 °C. Pellets were resuspended in 20 mL PBS, 1 × EDTA-free cOmplete Protease Inhibitor Cocktail (Sigma), cells were lysed using a microfluidizer (Microfluidics), and the cell lysate centrifuged at 10,000 rpm for 30 min at 4 °C. Cleared lysates were applied to Ni–NTA resin, rotating end over end at 4 °C for 1 h to allow adsorption, and mixture was transferred to a plastic column. After allowing flow-through of the adsorption mix, the resin was washed with PBS containing steps of 0 mM, 20 mM, 50 mM, 80 mM, and 120 mM imidazole, followed by elution of the protein with PBS containing 500 mM imidazole, pH = 7.2. Protein purity was determined by SDS-PAGE gel and Coomassie staining, and protein concentrations were determined using Bradford reagent (Bio-Rad). Protein was dialyzed overnight into 10 mM MES (pH = 6.5), 300 mM NaCl, 1 mM EDTA using dialysis cassettes (Slide-a-Lyzer Cassettes, Thermo), then either stored short-term at 4 °C, or long-term by adding 10% glycerol and 5 mM DTT before flash freezing for storage at − 80 °C.

ILY treatment. Approximately 5 × 105 WT 293 T cells were seeded overnight in 12 well plates. To perform inhibitor experiments, cells were pretreated with 100 nM ILYPP or an equivalent volume of buffer per well and incubated at 37 °C, 5% CO2 for 1 h. After pretreatment, cells were challenged with 30 nM of ILYWT or buffer, incubated for an additional 2 h, and assayed for pore formation (See Pore Formation Assay).

Focal adhesion immunofluorescence staining. HeLa cells were seeded on glass coverslips overnight in 24-well plates. Cells were wash and then challenged at MOI = 5, centrifuged for 5 min at 200xg, then immediately washed and fixed in 4% PFA. The fixed cells were then washed with 0.05 M Tris buffered saline pH 8.0 (TBS) permeabilized in TBS containing 0.1% Triton X-100 for 2–5 min and blocked with TBS containing 1% BSA. Cells were incubated with anti-phosphotyrosine, clone 4G10 (EMD Millipore) (1:200 in blocking buffer), washed 3 times, and incubated with donkey anti-mouse IgG-Alexa-Fluor 594 (Jackson ImmunoResearch Laboratories). Coverslips were stained with Hoechst, washed, and mounted with ProLong Glass Antifade (Invitrogen). Images were taken with Zeiss AxioObserver.Z1 fluorescent microscope. Focal adhesions were identified and measured in ImageJ using a custom macro that automates various functions to minimize background, increase contrast, and enhance edge detection to identify focal adhesion particles, based on a previously published workflow41. See Supplementary materials for macro details.

GM1 immunofluorescence staining. HeLa cells were seeded overnight in DMEM containing 10% fetal bovine serum on glass coverslips in 24-well plates. Prior to infection, the culture medium was aspirated and fresh culture medium containing cholera toxin B (CtxB) (Vybrant Lipid Raft Labeling Kit, Molecular Probes) was added. Cells were then infected at MOI = 5 with Yptb diluted in DMEM + 10% FBS so that the final concentration of CtxB was 2 μg/mL in each well. Plates were placed in centrifuge, subjected to 5 min spin at 200xg, then coverslips were washed three times with cold medium, incubated with anti-CtxB at 4 °C for 15 min, washed three times with cold PBS, fixed in 4% PBS containing 4% PFA, washed three times in PBS, stained with Hoechst (1:10,000) and mounted with ProLong Glass Antifade (Invitrogen).

Quantification of polarization index for CtxB localization. To measure asymmetric localization of AlexaFluor594-CtxB, multichannel 63X CZI images were captured from an Axio Observer Z1 inverted microscope, using Hoescht staining to perform nuclear segmentation, and AlexaFluor594 to quantify perinuclear receptor aggregation of CtxB. Nuclei were first segmented using a Python script incorporating Cellpose-SAM60 with segmentation masks being cached per field, followed by inspection using Hoescht/mask overlay images (Supplemental Fig. S5D). Nuclei within 20 pixels of the image border were excluded from statistical comparisons because perinuclear-localizing fluorescence could be partially outside the field of view. Once nuclear segmentation was completed, a Polarization Index (R) was calculated by taking each segmented nucleus and defining the associated perinuclear AlexaFluor594 by thresholding the AlexaFluor594 channel with Otsu’s method61, excluding pixels inside the nuclei, and assigning extranuclear pixels above the Otsu threshold to the nearest nucleus by Euclidean distance transform. The assigned CtxB regions were restricted to a 1.0 μm perinuclear shell. The Polarization Index was then quantified as the intensity-weighted circular resultant length (R), of the assigned mCherry pixels around the nuclear centroid. To this end, a routine was employed to perform these tasks as follows.

For each nucleus, the code segmented the nuclear Hoescht signal, found the above-background perinuclear AlexaFluor594 pixels that defined CtxB localization, then assigned those pixels to the nearest nucleus, computing a one-sidedness score (R).

To calculate R, for the AlexaFluor594 channel pixel i, let wi be its intensity and θi be its angle around the nucleus center:

graphic file with name d33e1548.gif

The asymmetry score was then determined as the intensity-weighted circular resultant length by:

graphic file with name d33e1553.gif

This routine can be accessed on Zenodo, by the Digital Object Identifier at https://doi.org/10.5281/zenodo.21627640 with the segmented images analyzed for Fig. 6 at: https://zenodo.org/records/21627640.

Lipid extraction and data analysis. Lipids were extracted from WT and CD59 KO 293 T cells by the Folch extraction method44 as follows. CD59 KO and WT 293 T cells were grown in DMEM + 10% FBS until ~ 80% confluency in one 10 cm plate per sample replicate, and medium was changed 2 h prior to harvesting. Cells were rinsed with PBS, lifted with 0.05% trypsin, spun down for 5 min at 200xg, washed with PBS, and resuspended with PBS in a total volume of 200μL. Cells were transferred to glass vials and 2:1 chloroform: methanol was added to a final volume of 4 mL. Samples were then agitated for 30 min on an orbital shaker at RT before 800μL water was added, vortexed 1 min, and allowed to stand for 10 min before centrifuging for 5 min at 1000xg to separate into three phases. The lower phase containing nonpolar lipids was carefully transferred with a glass pipette from the vial into the microtube, then evaporated under nitrogen and stored at − 80 °C. Samples were then analyzed via high-resolution LC–MS/MS, and the lipids were identified and quantified with LipidSearch software by the BIDMC-Harvard Mass Spectrometry Facility according to their published protocol (special thanks to Dr. John Asara, Director)44. Lipid peak data were normalized by percent abundance within each sample. PCA analysis was performed using MetaboAnalyst 5.0. Lipid pathway analysis performed using LIPIDMAPS BioPan software62–65.

Supplementary Information

Acknowledgements

We would like to thank Dr. Rodney Tweten (Oklahoma University Health Science Center) for the kind gift of plasmids encoding intermedilysin derivatives and for discussions during the early stages of this work. We would like to thank Stephen Kwok and Alan Parmelee from the Tufts Flow Cytometry Core Facility for assistance in flow cytometry, Dr. Joan Mecsas and her lab for Yersinia strains and discussions, as well as Drs. Marta Gaglia and Katya Heldwein for experimental suggestions. We thank Drs. Efrat Hamami, Kevin Manera, Atish RoyChowdhury and Bixi He for critical review of the manuscript. This work was supported by NIAID awards R21AI085250, and R01AI110684 to R.R.I. KJD was supported by a NIAID Training Grant T32AI007422 and KLS was supported by NRSA postdoctoral fellowship F32 AI 082914-01 and Natalie V. Zucker Fellowship. BBA and JJW were supported, in whole or in part, by the Gates Foundation INV-070003. The conclusions and opinions expressed in this work are those of the author(s) alone and shall not be attributed to the Foundation.

Author contributions

Kristen Davis: conceptualized and designed the analysis, collected, analyzed, and interpreted the data, writing of original draft, editing of the paper; Kerri Sheahan: conceptualization, constructed CD59 KO cell line, collected preliminary data; Connor Murphy: conceptualization, collected preliminary data; Joshua Whiteley wrote code and performed image analysis; Bree Aldridge oversaw methodology and interpretation of data; Ralph Isberg: conceptualization and design of analysis, funding acquisition, project administration, methodology, interpretation of data, editing and review of manuscript.

Funding

This work was supported by NIAID awards R21AI085250, and R01AI110684 to R.R.I. KJD was supported by a NIAID Training Grant T32AI007422 and KLS was supported by NRSA postdoctoral fellowship F32 AI 082914–01 and Natalie V. Zucker Fellowship. Work performed by JJA and BBA was funded, in whole or in part, by the Gates Foundation INV-070003. The conclusions and opinions expressed in this work are those of the author(s) alone and shall not be attributed to the Foundation. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. Please note works submitted as a preprint have not undergone a peer review process.

Data availability

All data supporting the findings of this study are available within the paper and within the Supplementary Information, while code used to generate data along with raw data is available on GitHub (https://github.com/joshwhiteley/signal-aggregation-comparison).

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Dewoody, R. S., Merritt, P. M. & Marketon, M. M. Regulation of the Yersinia type III secretion system: Traffic control. Front. Cell. Infect. Microbiol.3, 4 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cornelis, G. R. The type III secretion injectisome. Nat. Rev. Microbiol.4, 811–825 (2006). [DOI] [PubMed] [Google Scholar]
  • 3.Bliska, J. B., Wang, X., Viboud, G. I. & Brodsky, I. E. Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors. Cell. Microbiol.15, 1622–1631 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cornelis, G. R. et al. The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Biol. Rev.62, 1315–1352 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Portnoy, D. A. & Falkow, S. Virulence-associated plasmids from Yersinia enterocolitica and Yersinia pestis. J. Bacteriol.148, 877–883 (1981). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Gemski, P., Lazere, J. R., Casey, T. & Wohlhieter, J. A. Presence of a virulence-associated plasmid in Yersinia pseudotuberculosis. Infect. Immun.28, 1044–1047 (1980). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Matteï, P. J. et al. Membrane targeting and pore formation by the type III secretion system translocon. FEBS J.278, 414–426 (2011). [DOI] [PubMed] [Google Scholar]
  • 8.Viboud, G. I., Mejía, E. & Bliska, J. B. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection. Cell. Microbiol.8, 1504–1515 (2006). [DOI] [PubMed] [Google Scholar]
  • 9.Aepfelbacher, M. et al. Characterization of YopT effects on Rho GTPases in Yersinia enterocolitica-infected cells. J. Biol. Chem.278, 33217–33223 (2003). [DOI] [PubMed] [Google Scholar]
  • 10.Logsdon, L. K. & Mecsas, J. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect. Immun.71, 4595–4607 (2003). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Black, D. S. & Bliska, J. B. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol. Microbiol.37, 515–527 (2000). [DOI] [PubMed] [Google Scholar]
  • 12.von Pawel-Rammingen, U. et al. GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol. Microbiol.36, 737–748 (2000). [DOI] [PubMed] [Google Scholar]
  • 13.Mejía, E., Bliska, J. B. & Viboud, G. I. Yersinia controls type III effector delivery into host cells by modulating Rho activity. PLoS Pathog.4, e3 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Blondel, C. J. et al. CRISPR/Cas9 screens reveal requirements for host cell sulfation and fucosylation in bacterial type III secretion system-mediated cytotoxicity. Cell Host Microbe20, 226–237 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Deruelle, V. et al. The bacterial toxin ExoU requires a host trafficking chaperone for transportation and to induce necrosis. Nat Commun12, 4024 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Swimm, A. I. & Kalman, D. Cytosolic extract induces Tir translocation and pedestals in EPEC-infected red blood cells. PLoS Pathog.4, e4 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sheahan, K. L. & Isberg, R. R. Identification of mammalian proteins that collaborate with type III secretion system function: Involvement of a chemokine receptor in supporting translocon activity. MBio6, e02023 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kimberley, F. C., Sivasankar, B. & Paul, M. B. Alternative roles for CD59. Mol Immunol44, 73–81 (2007). [DOI] [PubMed] [Google Scholar]
  • 19.Sugita, Y., Nakano, Y. & Tomita, M. Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels. J. Biochem.104, 633–637 (1988). [DOI] [PubMed] [Google Scholar]
  • 20.Holguin, M. H., Fredrick, L. R., Bernshaw, N. J., Wilcox, L. A. & Parker, C. J. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J. Clin. Invest.84, 7–17 (1989). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rollins, S. A. & Sims, P. J. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J. Immunol.144, 3478–3483 (1990). [PubMed] [Google Scholar]
  • 22.Giddings, K. S., Zhao, J., Sims, P. J. & Tweten, R. K. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin. Nat. Struct. Mol. Biol.11, 1173–1178 (2004). [DOI] [PubMed] [Google Scholar]
  • 23.Farrand, A. J. et al. The cholesterol-dependent cytolysin membrane-binding interface discriminates lipid environments of cholesterol to support beta-barrel pore insertion. J. Biol. Chem.290, 17733–17744 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Simons, K. & Ehehalt, R. Cholesterol, lipid rafts, and disease. J. Clin. Invest.110, 597–603 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hayward, R. D. et al. Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells. Mol. Microbiol.56, 590–603 (2005). [DOI] [PubMed] [Google Scholar]
  • 26.van der Goot, F. G., Tran van Nhieu, G., Allaoui, A., Sansonetti, P. & Lafont, F. Rafts can trigger contact-mediated secretion of bacterial effectors via a lipid-based mechanism. J. Biol. Chem.279, 47792–47798 (2004). [DOI] [PubMed] [Google Scholar]
  • 27.Lafont, F. & van der Goot, F. G. Bacterial invasion via lipid rafts. Cell. Microbiol.7, 613–620 (2005). [DOI] [PubMed] [Google Scholar]
  • 28.Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods11, 783–784 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Viboud, G. I. & Bliska, J. B. Yersinia outer proteins: Role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol.59, 69–89 (2005). [DOI] [PubMed] [Google Scholar]
  • 30.Harmon, D. E., Davis, A. J., Castillo, C. & Mecsas, J. Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis. Antimicrob. Agents Chemother.54, 3241–3254 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Soltani, C. E., Hotze, E. M., Johnson, A. E. & Tweten, R. K. Specific protein-membrane contacts are required for prepore and pore assembly by a cholesterol-dependent cytolysin. J. Biol. Chem.282, 15709–15716 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Guignot, J. & Tran Van Nhieu, G. Bacterial control of pores induced by the type III secretion system: Mind the gap. Front. Immunol.7, 84 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Knodler, L. A., Celli, J. & Finlay, B. B. Pathogenic trickery: Deception of host cell processes. Nat. Rev. Mol. Cell Biol.2, 578–588 (2001). [DOI] [PubMed] [Google Scholar]
  • 34.Fuentes, D. E. & Butler, P. J. Coordinated mechanosensitivity of membrane rafts and focal adhesions. Cell. Mol. Bioeng.5, 143–154 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Black, D. S., Montagna, L. G., Zitsmann, S. & Bliska, J. B. Identification of an amino-terminal substrate-binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets. Mol. Microbiol.29, 1263–1274 (1998). [DOI] [PubMed] [Google Scholar]
  • 36.Rolán, H. G., Durand, E. A. & Mecsas, J. Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection. Cell Host Microbe14, 306–317 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Andersson, K. et al. YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis. Mol. Microbiol.20, 1057–1069 (1996). [DOI] [PubMed] [Google Scholar]
  • 38.Persson, C., Carballeira, N., Wolf-Watz, H. & Fällman, M. The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J.16, 2307–2318 (1997). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Black, D. S. & Bliska, J. B. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. EMBO J.16, 2730–2744 (1997). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lipp, A. M. et al. Lck mediates signal transmission from CD59 to the TCR/CD3 pathway in Jurkat T cells. PLoS ONE9, e85934 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Horzum, U., Ozdil, B. & Pesen-Okvur, D. Step-by-step quantitative analysis of focal adhesions. MethodsX1, 56–59 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Aigal, S., Claudinon, J. & Romer, W. Plasma membrane reorganization: A glycolipid gateway for microbes. Biochim. Biophys. Acta1853, 858–871 (2015). [DOI] [PubMed] [Google Scholar]
  • 43.Klymchenko, A. S. & Kreder, R. Fluorescent probes for lipid rafts: From model membranes to living cells. Chem. Biol.21, 97–113 (2014). [DOI] [PubMed] [Google Scholar]
  • 44.Breitkopf, S. B. et al. A relative quantitative positive/negative ion switching method for untargeted lipidomics via high resolution LC-MS/MS from any biological source. Metabolomics 10.1007/s11306-016-1157-8 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kinoshita, M. et al. Raft-based sphingomyelin interactions revealed by new fluorescent sphingomyelin analogs. J. Cell Biol.216, 1183–1204 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Niemela, P. S., Hyvonen, M. T. & Vattulainen, I. Influence of chain length and unsaturation on sphingomyelin bilayers. Biophys. J.90, 851–863 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Gaud, C. et al. BioPAN: A web-based tool to explore mammalian lipidome metabolic pathways on LIPID MAPS. F1000Res9(10), 4 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Cockcroft, S. Mammalian lipids: Structure, synthesis and function. Essays Biochem.65, 813–845 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Shanbhag, K., Mhetre, A., Khandelwal, N. & Kamat, S. S. The lysophosphatidylserines-an emerging class of signalling lysophospholipids. J. Membr. Biol.253, 381–397 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Wang, L. N., Gao, M. H., Wang, B., Cong, B. B. & Zhang, S. C. A role for GPI-CD59 in promoting T-cell signal transduction via LAT. Oncol. Lett.15, 4873–4881 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Popik, W., Alce, T. M. & Au, W. C. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J. Virol.76, 4709–4722 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Brandel, A. et al. The Gb3-enriched CD59/flotillin plasma membrane domain regulates host cell invasion by Pseudomonas aeruginosa. Cell. Mol. Life Sci.78, 3637–3656 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Chinnapen, D. J., Chinnapen, H., Saslowsky, D. & Lencer, W. I. Rafting with cholera toxin: Endocytosis and trafficking from plasma membrane to ER. FEMS Microbiol. Lett.266, 129–137 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Torres, M. et al. Lipids in pathophysiology and development of the membrane lipid therapy: New bioactive lipids. Membranes 10.3390/membranes11120919 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Skotland, T., Kavaliauskiene, S. & Sandvig, K. The role of lipid species in membranes and cancer-related changes. Cancer Metastasis Rev.39, 343–360 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Iglesias-Bartolome, R. et al. Differential endocytic trafficking of neuropathy-associated antibodies to GM1 ganglioside and cholera toxin in epithelial and neural cells. Biochim. Biophys. Acta1788, 2526–2540 (2009). [DOI] [PubMed] [Google Scholar]
  • 57.Arumugam, S. et al. Ceramide structure dictates glycosphingolipid nanodomain assembly and function. Nat. Commun.12, 3675 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Nguyen, G. T., McCabe, A. L., Fasciano, A. C. & Mecsas, J. Detection of cells translocated with Yersinia Yops in infected tissues using β-lactamase fusions. Methods Mol. Biol.2010, 117–139 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.LaChapelle, S., Tweten, R. K. & Hotze, E. M. Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis. J. Biol. Chem.284, 12719–12726 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Stringer, C. & Pachitariu, M. Cellpose3: One-click image restoration for improved cellular segmentation. Nat. Methods22, 592–599 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Otsu, N. A threshold selection method from gray-level histograms. IEEE Trans. Syst. Man Cybern.9, 62–66 (1979). [Google Scholar]
  • 62.Osei-Owusu, P., Charlton, T. M., Kim, H. K., Missiakas, D. & Schneewind, O. FPR1 is the plague receptor on host immune cells. Nature574, 57–62 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Cai, B. et al. Rapid degradation of the complement regulator, CD59, by a novel inhibitor. J. Biol. Chem.289, 12109–12125 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Vanni, S., Riccardi, L., Palermo, G. & De Vivo, M. Structure and dynamics of the acyl chains in the membrane trafficking and enzymatic processing of lipids. Acc. Chem. Res.52, 3087–3096 (2019). [DOI] [PubMed] [Google Scholar]
  • 65.Rawicz, W., Olbrich, K. C., McIntosh, T., Needham, D. & Evans, E. Effect of chain length and unsaturation on elasticity of lipid bilayers. Biophys. J.79, 328–339 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Maldonado-Arocho, F. J., Green, C., Fisher, M. L., Paczosa, M. K. & Mecsas, J. Adhesins and host serum factors drive Yop translocation by yersinia into professional phagocytes during animal infection. PLoS Pathog.9, e1003415 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Crimmins, G. T. et al. Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes. PLoS Pathog.8, e1002828 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

All data supporting the findings of this study are available within the paper and within the Supplementary Information, while code used to generate data along with raw data is available on GitHub (https://github.com/joshwhiteley/signal-aggregation-comparison).


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES